{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T09:51:06Z","timestamp":1721814666324},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,3]]},"DOI":"10.7759\/cureus.16134","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T10:32:16Z","timestamp":1625308336000},"source":"Crossref","is-referenced-by-count":2,"title":["When is Sentinel Lymph Node Biopsy Useful in Ductal Carcinoma In Situ? The Experience at a Latin American Cancer Center"],"prefix":"10.7759","author":[{"given":"Sandra E","family":"Diaz  Casas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilmar  A","family":"Serrano Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson A","family":"Buelvas G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M","family":"Osorio Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"\u00c1ngel Aristiz\u00e1bal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis  H","family":"Guzm\u00e1n Abisaab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Garcia Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Lehmann Mosquera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Cervera-Bonilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Sanchez Pedraza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Global cancer observatory. International Agency for Research on Cancer. (2020). Accessed: December 20, 2020: https:\/\/gco.iarc.fr\/today\/fact-sheets-cancers.."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2019.08.018","article-title":"Ductal carcinoma in situ in 2019: diagnosis, treatment, prognosis [Article in French]","volume":"48","author":"Cutuli B","year":"2019","unstructured":"Cutuli B. Ductal carcinoma in situ in 2019: diagnosis, treatment, prognosis [Article in French]. Presse Med. 2019, 48:1112-2. 10.1016\/j.lpm.2019.08.018","journal-title":"Presse Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan D","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011, 144:646-74. 10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-11-1276","article-title":"Current treatment and clinical trial developments for ductal carcinoma in situ of the breast","volume":"12","author":"Boughey JC","year":"2007","unstructured":"Boughey JC, Gonzalez RJ, Bonner E, Kuerer HM. Current treatment and clinical trial developments for ductal carcinoma in situ of the breast. Oncologist. 2007, 12:1276-87. 10.1634\/theoncologist.12-11-1276","journal-title":"Oncologist"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgq035","article-title":"Ductal carcinoma in situ: terminology, classification, and natural history","volume":"2010","author":"Allred DC","year":"2010","unstructured":"Allred DC. Ductal carcinoma in situ: terminology, classification, and natural history. J Natl Cancer Inst Monogr. 2010, 2010:134-8. 10.1093\/jncimonographs\/lgq035","journal-title":"J Natl Cancer Inst Monogr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.11102368","article-title":"Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer","volume":"260","author":"Brennan ME","year":"2011","unstructured":"Brennan ME, Turner RM, Ciatto S, Marinovich ML, French JR, Macaskill P, Houssami N. Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Radiology. 2011, 260:119-28. 10.1148\/radiol.11102368","journal-title":"Radiology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-005-9025-7","article-title":"Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer","volume":"95","author":"Fleissig A","year":"2006","unstructured":"Fleissig A, Fallowfield LJ, Langridge CI, et al.. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat. 2006, 95:279-93. 10.1007\/s10549-005-9025-7","journal-title":"Breast Cancer Res Treat"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.138.3.309","article-title":"Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast","volume":"138","author":"Intra M","year":"2003","unstructured":"Intra M, Veronesi P, Mazzarol G, et al.. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg. 2003, 138:309-13. 10.1001\/archsurg.138.3.309","journal-title":"Arch Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2016.10.002","article-title":"Sentinel node procedure obsolete in lumpectomy for ductal carcinoma in situ","volume":"17","author":"Heymans C","year":"2017","unstructured":"Heymans C, van Bastelaar J, Visschers RGJ, Vissers YLJ. Sentinel node procedure obsolete in lumpectomy for ductal carcinoma in situ. Clin Breast Cancer. 2017, 17:e87-93. 10.1016\/j.clbc.2016.10.002","journal-title":"Clin Breast Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-016-3783-2","article-title":"Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy","volume":"156","author":"van Roozendaal LM","year":"2016","unstructured":"van Roozendaal LM, Goorts B, Klinkert M, et al.. Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy. Breast Cancer Res Treat. 2016, 156:517-25. 10.1007\/s10549-016-3783-2","journal-title":"Breast Cancer Res Treat"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.1177","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"32","author":"Lyman GH","year":"2014","unstructured":"Lyman GH, Temin S, Edge SB, et al.. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2014, 32:1365-83. 10.1200\/JCO.2013.54.1177","journal-title":"J Clin Oncol"},{"key":"ref12","unstructured":"NCCN. Clinical Practice Guidelines in Oncology-Breast Cancer Version 4. (2020). Accessed: December 20, 2020: http:\/\/www.nccn.com."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5322-0","article-title":"Utilization of axillary surgery for patients with ductal carcinoma in situ: a report from the National Cancer Data Base","volume":"23","author":"Miller ME","year":"2016","unstructured":"Miller ME, Kyrillos A, Yao K, Kantor O, Tseng J, Winchester DJ, Shulman LN. Utilization of axillary surgery for patients with ductal carcinoma in situ: a report from the National Cancer Data Base. Ann Surg Oncol. 2016, 23:3337-46. 10.1245\/s10434-016-5322-0","journal-title":"Ann Surg Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2016.04.019","article-title":"Is sentinel lymph node biopsy indicated in patients with a diagnosis of ductal carcinoma in\u00a0situ? A systematic literature review and meta-analysis","volume":"213","author":"El Hage Chehade H","year":"2017","unstructured":"El Hage Chehade H, Headon H, Wazir U, Abtar H, Kasem A, Mokbel K. Is sentinel lymph node biopsy indicated in patients with a diagnosis of ductal carcinoma in\u00a0situ? A systematic literature review and meta-analysis. Am J Surg. 2017, 213:171-80. 10.1016\/j.amjsurg.2016.04.019","journal-title":"Am J Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkz052","article-title":"Long-term outcomes of sentinel lymph node biopsy for ductal carcinoma in situ","volume":"3","author":"Hung P","year":"2019","unstructured":"Hung P, Wang SY, Killelea BK, Mougalian SS, Evans SB, Sedghi T, Gross CP. Long-term outcomes of sentinel lymph node biopsy for ductal carcinoma in situ. JNCI Cancer Spectr. 2019, 3:pkz052. 10.1093\/jncics\/pkz052","journal-title":"JNCI Cancer Spectr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/tbj.13737","article-title":"Sentinel lymph node positivity in patients undergoing mastectomies for ductal carcinoma in situ (DCIS)","volume":"26","author":"Price A","year":"2020","unstructured":"Price A, Schnabel F, Chun J, et al.. Sentinel lymph node positivity in patients undergoing mastectomies for ductal carcinoma in situ (DCIS). Breast J. 2020, 26:931-6. 10.1111\/tbj.13737","journal-title":"Breast J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v7.i2.258","article-title":"Sentinel lymph node biopsy in clinically detected ductal carcinoma in situ","volume":"7","author":"Al-Ameer AY","year":"2016","unstructured":"Al-Ameer AY, Al Nefaie S, Al Johani B, et al.. Sentinel lymph node biopsy in clinically detected ductal carcinoma in situ. World J Clin Oncol. 2016, 7:258-64. 10.5306\/wjco.v7.i2.258","journal-title":"World J Clin Oncol"},{"key":"ref18","article-title":"Sentinel lymph node metastasis in patients with ductal breast carcinoma in situ [Article on Spanish]","volume":"82","author":"Ruvalcaba-Lim\u00f3n E","year":"2014","unstructured":"Ruvalcaba-Lim\u00f3n E, de Jes\u00fas Gardu\u00f1o-Raya M, Bautista-Pi\u00f1a V, Trejo-Mart\u00ednez C, Maffuz-Aziz A, Rodr\u00edguez-Cuevas S. Sentinel lymph node metastasis in patients with ductal breast carcinoma in situ [Article on Spanish]. Cir Cir. 2014, 82:129-41.","journal-title":"Cir Cir"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.senol.2017.01.001","article-title":"Utility of sentinel lymph node biopsy in ductal carcinoma in situ diagnosed with a vacuum-assisted core biopsy [Article on Spanish]","volume":"30","author":"Acosta-Mar\u00edn V","year":"2017","unstructured":"Acosta-Mar\u00edn V, Acosta-Freites V, Ram\u00edrez AK, et al.. Utility of sentinel lymph node biopsy in ductal carcinoma in situ diagnosed with a vacuum-assisted core biopsy [Article on Spanish]. Rev Senol Patol Mamar. 2017, 30:15-20. 10.1016\/j.senol.2017.01.001","journal-title":"Rev Senol Patol Mamar"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21535","article-title":"Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection","volume":"102","author":"Ashikaga T","year":"2010","unstructured":"Ashikaga T, Krag DN, Land SR, et al.. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol. 2010, 102:111-8. 10.1002\/jso.21535","journal-title":"J Surg Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000245472.47748.ec","article-title":"Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients","volume":"245","author":"Langer I","year":"2007","unstructured":"Langer I, Guller U, Berclaz G, et al.. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg. 2007, 245:452-61. 10.1097\/01.sla.0000245472.47748.ec","journal-title":"Ann Surg"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2010.08.007","article-title":"Ductal carcinoma in-situ: an update for clinical practice","volume":"20","author":"Patani N","year":"2011","unstructured":"Patani N, Khaled Y, Al Reefy S, Mokbel K. Ductal carcinoma in-situ: an update for clinical practice. Surg Oncol. 2011, 20:e23-31. 10.1016\/j.suronc.2010.08.007","journal-title":"Surg Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/58666-when-is-sentinel-lymph-node-biopsy-useful-in-ductal-carcinoma-in-situ-the-experience-at-a-latin-american-cancer-center","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:09Z","timestamp":1707507069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/58666-when-is-sentinel-lymph-node-biopsy-useful-in-ductal-carcinoma-in-situ-the-experience-at-a-latin-american-cancer-center"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,3]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.16134","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,3]]}}}